Management of Pseudogout

Introduction to Treatment

The American College of Rheumatology strongly recommends corticosteroids as a first-line option for acute crystal arthropathy flares, including pseudogout, in patients with concurrent Lyme disease 1, 2
Prednisone burst therapy is generally safe and appropriate for treating pseudogout in a patient with concurrent Lyme disease, provided the patient is also receiving appropriate antibiotic therapy for Lyme disease 1, 3

Typical corticosteroid regimens for pseudogout include methylprednisolone dose pack or prednisone 30-35mg daily for 3-5 days with tapering, as recommended by the American College of Rheumatology 1, 2
Alternative options include oral prednisone (30-35mg daily for 3-5 days) 4, intra-articular corticosteroid injection (if single joint involvement), and low-dose colchicine (if no contraindications) 2, 1

Concurrent antibiotic therapy is essential when using corticosteroids in a patient with Lyme disease, with appropriate antibiotics including doxycycline, amoxicillin, cefuroxime axetil, and IV ceftriaxone for severe manifestations 3
The American College of Rheumatology suggests that concurrent antibiotic therapy is crucial when using corticosteroids in patients with Lyme disease, with antibiotics such as doxycycline and amoxicillin 3

Corticosteroids should only be used with concurrent appropriate antibiotic therapy for Lyme disease, and treatment should be limited to short-term use (5-7 days) for pseudogout, while completing the full antibiotic course (typically 14-21 days) for Lyme disease 3
In patients with Lyme carditis or neurologic involvement, IV antibiotics may be preferred initially until clinical improvement, and prednisone can still be used for pseudogout management 3

Monitor for resolution of pseudogout symptoms, ensure appropriate response to Lyme disease treatment, and watch for potential short-term corticosteroid side effects (hyperglycemia, mood changes) 1, 3, 2
Follow up to confirm resolution of both conditions, and consider alternative therapies if pseudogout is resistant to initial corticosteroid treatment 1, 3, 2
Patients should be monitored for short-term effects like elevated blood glucose, and urate-lowering therapy (ULT) should be considered during the flare if indicated for long-term management 2, 1